The preparation of large quantities of highly pure peptide for pharmacological and physiological studies in both laboratory and clinical settings.
Patent protection is available with the possibility for non-exclusive or exclusive licensure.
The development of an assay to measure levels of this enzyme may provide an efficient, non-invasive method for the diagnosis of lung cancer at early stages, leading to a more effective treatment of the disease. We also foresee the possibility of using this protein as a ligand to specifically target anti-tumor agents to affected tissue. Future studies would involve the evaluation of tumor and tissue samples from both animal and human models and the development of monoclonal antibodies specific for the diagnostic protein. Patent protection is being sought for this invention. Patent protection is being sought for this invention.